---
title: "《新股》药捷安康公开发售超购近 3,419 倍  一手中签仅 0.8%"
description: "药捷安康的公开发售超购近 3,419 倍，一手中签率仅为 0.8%。国际发售认购倍数为 0.97 倍，公开发售股份增至 305.7 万股，占总发售 20%。此次全球发售 1,528.1 万股，招股价为 13.15 元，预计集资净额为 1.61 亿元。五名基石投资者共认购 1.3 亿元股份，股份预计于周一 (23 日) 挂牌。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/245574988.md"
published_at: "2025-06-22T11:55:27.000Z"
---

# 《新股》药捷安康公开发售超购近 3,419 倍  一手中签仅 0.8%

> 药捷安康的公开发售超购近 3,419 倍，一手中签率仅为 0.8%。国际发售认购倍数为 0.97 倍，公开发售股份增至 305.7 万股，占总发售 20%。此次全球发售 1,528.1 万股，招股价为 13.15 元，预计集资净额为 1.61 亿元。五名基石投资者共认购 1.3 亿元股份，股份预计于周一 (23 日) 挂牌。

药捷安康－B(02617.HK) 公布招股结果，香港公开发售接获 3,419.87 倍认购，一手 (500 股) 中签率 0.8%。国际发售录得 0.97 倍认购。经重新分配，公开发售股份已增加至 305.7 万股，占发售总数 20%。股份预期周一 (23 日) 挂牌。

生物制药公司药捷安康是次全球发售 1,528.1 万股，公开发售占 10%。招股价 13.15 元，集资净额 1.61 亿元。五名基石投资者江北医药、康方生物 (09926.HK) 华盛敦行、药石地平线及科瓴安合共认购 1.3 亿元公司股份。

### Related Stocks

- [02617.HK - 药捷安康-B](https://longbridge.com/zh-CN/quote/02617.HK.md)
- [09926.HK - 康方生物](https://longbridge.com/zh-CN/quote/09926.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sands China Hosts The Second Macao Technological Innovation Exploration | Sands China hosted the second Macao Technological Innovation Exploration in Lisbon, supporting Macao entrepreneurs. The  | [Link](https://longbridge.com/zh-CN/news/276491972.md) |
| Auranova Announces Closing of Private Placement of Common Shares | Auranova Resources Inc. has successfully closed a non-brokered private placement, issuing 2,858,020 common shares at $0. | [Link](https://longbridge.com/zh-CN/news/276494659.md) |
| Usha Resources Options Ontario Rubidium Ridge Project to Panther Minerals | Usha Resources has signed an agreement with Panther Minerals for the acquisition of a 100% interest in its Rubidium Ridg | [Link](https://longbridge.com/zh-CN/news/276500712.md) |
| Ventia Services Group Limited (VNT) was upgraded to a Buy Rating at RBC Capital | Ventia Services Group Limited (VNT) was upgraded to a Buy rating by RBC Capital with a price target of A$6.25, as announ | [Link](https://longbridge.com/zh-CN/news/276499967.md) |
| As Pentagon Races to Deploy AI, Operational Challenges Highlight Risks | The Pentagon is facing operational challenges in deploying AI, with mixed results from recent exercises. Issues include  | [Link](https://longbridge.com/zh-CN/news/276494929.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。